Not logged inPrognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113) (vol 7, 100552, 2024)
Hartlapp, I.; Valta-Seufzer, D.; Siveke, J. T.; Alguel, H.; Goekkurt, E.; Siegler, G.; Martens, U. M.; Waldschmidt, D.; Pelzer, U.; Fuchs, M.; Kullmann, F.; Boeck, S.; Ettrich, T. J.; Held, S.; Keller, R.; Anger, F.; Germer, C. T.; Stang, A.; Kimmel, B.; Heinemann, V.; Kunzmann, V. .png)
Share.png)
SaveShare Save Evaluation of conversion therapy in patients undergoing secondary resection of metastases in curative intent within the FIRE-3 (AIO KRK-0306) studyvon Einem, J. C.; Heinemann, V.; Modest, D. P.; Stahler, A.; Miller-Phillips, L.; von Weikersthal, L. Fischer; Decker, T.; Kiani, A.; Vehling-Kaiser, U.; Al-Batran, S-E.; Kahl, C.; Seipelt, G.; Kullmann, F.; Scheithauer, W.; Jung, A.; Kirchner, T.; Stintzing, S. Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
